MENU
BCTX
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
BriaCell Therapeutics (BCTX) Ownership - Who owns BriaCell Therapeutics?
Profile
Industry
N/A
Address
235 - 15th Street
Phone
+1 604 921-1810
Employees
12
Web
https://www.briacell.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
25.64M
P/E Ratio
N/A
Total Cash
5.79M
Projected Growth
N/A
Total Debt
26.96K
Revenue
N/A
Risk (Beta)
1.80
Dividend Yield
N/A
Total Cash/Share
0.13
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price
Fundamentals
BCTX
Capitalization
25.6M
P/E Ratio
N/A
Risk (Beta)
1.80
Dividend Yield
N/A
Total Cash
5.79M
Total Cash/Share
0.13
Total Debt
27K
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0%
Revenue
0
ROE
N/A
Book Value
4.04M
P/B Ratio
6.13
Cash Flow
N/A
Earnings
-0.89
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
82M
Current Ratio
1.65
Current Revenue Per Employee
N/A
Dividends Per Share - Security
N/A
EBITDA
-29.87M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-114.32
Shares Held By Institutions
562K
Shares Outstanding - Current
44.2M
Total Liabilities
6.7M
Total Volume MTD
N/A
Value
-1
Gain YTD
-90.410
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
Industry Biotechnology
Profile
Fundamentals
Details
Industry
N/A
Address
235 - 15th Street
Phone
+1 604 921-1810
Employees
12
Web
https://www.briacell.com